Prolor reports positive data of hemophilia drug
Prolor Biotech has reported the positive results from a comparative study of its biobetter longer-acting version of the hemophilia drug Factor VIIa, Factor VIIa-CTP in hemophilic mice.
Related Articles:
-
LifeScan OneTouch UltraSmart InDuo Test Strips, Box of 50 Lifescan – click on the image... Read Full Story » -
Market Watch CHICAGO, May 24, 2012 /PRNewswire via COMTEX/ -- Canadian Double-Lung Transplant... Read Full Story » -
REPORT HIGHLIGHTS The global market for sol-gel products reached $1.4 billion in 2011. It is... Read Full Story » -
Special 5 Packs of 2 – Soft Hands Gloves CEXP75SOO APEX/CAREX HEALTHCARE Med-Choice – click... Read Full Story » -
REPORT HIGHLIGHTS The total market for plastics additives is projected to increase from $39... Read Full Story »
Comments
